Published in
Taylor and Francis Group, Leukemia & Lymphoma, 1(64), p. 130-139, 2022
DOI: 10.1080/10428194.2022.2136956
Links
Tools
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
Journal article published in 2022 by
John Kuruvilla 
,
Philippe Armand,
Mehdi Hamadani,
Justin Kline,
Craig H. Moskowitz,
Moskowitz Ch,
David Avigan,
Pier Luigi Zinzani,
Joshua D. Brody ,
Stephen J. Schuster,
Alex F. Herrera,
Vincent Ribrag,
Brody Jd,
Franck Morschhauser ,
Herrera Af
and other authors.
,
Philippe Armand,
Mehdi Hamadani,
Justin Kline,
Craig H. Moskowitz,
Moskowitz Ch,
David Avigan,
Pier Luigi Zinzani,
Joshua D. Brody ,
Stephen J. Schuster,
Alex F. Herrera,
Vincent Ribrag,
Brody Jd,
Franck Morschhauser ,
Herrera Af
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 